AnaptysBio Inc buy Guggenheim
Start price
05.11.25
/
50%
€31.20
Target price
05.11.26
€87.01
Performance (%)
58.11%
Price
12.08.26
€49.13
Summary
This prediction is currently active. The BUY prediction by Guggenheim for AnaptysBio Inc has seen massive gains of 58.11%. This prediction currently runs until 05.11.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| AnaptysBio Inc | 4.692% | 4.692% |
| iShares Core DAX® | 0,63 % | 4,95 % |
| iShares Nasdaq 100 | 1,16 % | -1,16 % |
| iShares Nikkei 225® | 2,36 % | -1,35 % |
| iShares S&P 500 | 0,63 % | 1,38 % |
Comments by Guggenheim for this prediction
In the thread AnaptysBio Inc diskutieren
AnaptysBio (NASDAQ:ANAB) had its price target raised by analysts at Guggenheim from $90.00 to $100.00. They now have a "buy" rating on the stock.
Ratings data for ANAB provided by MarketBeat